Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04123665 · ClinicalTrials.gov registry record · Phase 3
A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 98
- Enrollment target
NCT04123665 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 98 participants.
The verdict
NCT04123665, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 98 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate and compare the gingival health of a test dentifrice (0.454% weight by weight \[w/w\] stannous fluoride) to a negative control dentifrice by comparing modified gingival index, bleeding index and plaque index scores.
Interventions
- DRUG Stannous fluoride
- DRUG Sodium monofluorophosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2013-05-28 |
| Est. Completion | 2013-12-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04123665
The ClinicalTrials.gov registry entry for NCT04123665 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stannous fluoride is the first listed.
NCT04123665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04123665 about?
NCT04123665 is a clinical study titled "A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride". The purpose of this study is to evaluate and compare the gingival health of a test dentifrice (0.454% weight by weight \[w/w\] stannous fluoride) to a negative control dentifrice by comparing modified gingival index, bleeding index and plaque index scores.
What is the current status of trial NCT04123665?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 98 participants. The study started on 2013-05-28. Estimated completion is 2013-12-11.
What interventions are being tested in trial NCT04123665?
The interventions under investigation include: Stannous fluoride (DRUG), Sodium monofluorophosphate (DRUG).
Who is sponsoring clinical trial NCT04123665?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.